Lights, Camera, Action: A close-up take on improving cancer patient outcomes with Lumicell
Tuesday, December 3, 5:30–7:30 p.m.
Koch Institute at MIT
500 Main Street, Building 76
Cambridge, MA 02139
Register to attend in person on Eventbrite
Register to attend online on Zoom
Join us as the multidisciplinary team behind Lumicell’s groundbreaking technology to improve outcomes for cancer patients recounts their journey from Koch Institute Frontier Research Program seed funding through recent FDA-approval, as well as the personal experiences that inspire them.
Lumicell’s technology is designed to address the challenge of cancer cells left behind during tumor removal surgery. These residual cancer cells can lead to costly and invasive additional treatments, drive disease relapse and progression, and worsen patient quality of life and survival. Lumicell’s cost effective, real-time imaging system for eliminating even single residual cancer cells during surgery was FDA-approved last spring for initial application in breast cancer, and will greatly improve patient outcomes as it pursues application in several additional solid tumors.
Featuring
Moungi Bawendi, PhD
Lester Wolfe Professor, Professor of Chemistry
Linda Griffith, PhD
School of Engineering Professor of Teaching Innovation, Professor of Biological and Mechanical Engineering
W. David Lee, '69 (II A), SM '70 (II)
Founder, Lumicell
Remarks begin at 5:30 p.m., with a reception to follow at 6:45 p.m.